Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
covid-19
3
×
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
unity biotechnology
wisconsin blog main
wisconsin top stories
astrazeneca
boston top stories
cancer
cancer immunotherapy
clinical trials
cystic fibrosis
deals
What
bio
3
×
roundup
acquisitions
ceo
daniel
gilead
o’day
sciences
abbvie’s
ahead
announced
biggest
biofourmis
bucks
build
buy
cancer
celebrate
chance
collabs
company’s
corner
covid
day
days
deal
debut
drug
dyne’s
forward
gilead’s
help
holiday
introduce
ipo
labor
looking
medicines
microbiome
month
Language
unset
3
×
Current search:
abbvie
×
unset
×
" new york blog main "
×
bio
×
covid-19
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More